Loading asset research
BioLineRx Ltd. American Depositary Shares
BLRXNasdaq · USD · StocksQuote as of · Exchange session not verified$2.51
-2.33%
Today
BLRX
Loading 1D prices…
Market cap
$12.2M
Volume
9.5K
52w high
$4.5652w low
$2.15Company profile
BioLineRx Ltd. American Depositary Shares
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Hevel Modi'in, United States
Employees
20
Fiscal year end
1231
CIK
1498403
Session & valuation
Open$2.58
Previous close$2.57
Day high$2.62
Day low$2.50
30-day avg. volume20.3K
Outstanding shares2.61B
Diluted EPS$0.00
Latest annual period
P/E (trailing)—
P/E (forward)-1.00
Price / book0.84
Beta0.69
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PHIOPhio Pharmaceuticals Corp. Common Stock | $12M | $0.00 | — | -$1.45 | +2.97% | Buy |
| KPRXKiora Pharmaceuticals Inc. Common Stock | $11.7M | $0.00 | — | -$2.64 | +2.71% | Buy |
| IMRNImmuron Limited American Depositary Shares | $11.7M | — | — | -$0.516 | -11.04% | Unrated |
| ASBPAspire Biopharma Holdings Inc. Common Stock | $12.7M | $6.2K | -394725.06% | -$16.38 | -0.66% | Unrated |
| TOVXTheriva Biologics Inc. Common Stock | $11.4M | $0.00 | — | -$2.08 | +4.17% | Buy |